Skip to Main Content

Author Details

Valina L Dawson
Institute for Cell Engineering, Johns Hopkins University School of Medicine
1988
389
129
PMIDPaper TitleJournal TitlePublished Year
36710687DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.J Parkinsons Dis2023
38019930Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson's disease.Sci Transl Med2023
37647389Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate.Sci Transl Med2023
38071218Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide.Nat Commun2023
37870275PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.EMBO Rep2023
36652533The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.Sci Transl Med2023
36710687DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.J Parkinsons Dis2023
37425943Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons.bioRxiv2023
37296356The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.Neurotherapeutics2023
37293032Pathological Tau transmission initiated by binding lymphocyte-activation gene 3.bioRxiv2023
37100955Apoptotic cell death in disease-Current understanding of the NCCD 2023.Cell Death Differ2023
36724785Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly.Am J Hum Genet2023
38019930Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson's disease.Sci Transl Med2023
38071218Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide.Nat Commun2023
37647389Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate.Sci Transl Med2023
37870275PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.EMBO Rep2023
37425943Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons.bioRxiv2023
37100955Apoptotic cell death in disease-Current understanding of the NCCD 2023.Cell Death Differ2023
37296356The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.Neurotherapeutics2023
37293032Pathological Tau transmission initiated by binding lymphocyte-activation gene 3.bioRxiv2023
36724785Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly.Am J Hum Genet2023
36652533The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.Sci Transl Med2023
34323016ADP-ribosyltransferases, an update on function and nomenclature.FEBS J2022
35394877STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.Proc Natl Acad Sci U S A2022
36044549Amelioration of pathologic α-synuclein-induced Parkinson's disease by irisin.Proc Natl Acad Sci U S A2022
35654037Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.Neuron2022
36103513Poly(ADP-ribose) promotes toxicity of <i>C9ORF72</i> arginine-rich dipeptide repeat proteins.Sci Transl Med2022
36280265The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA[D257A/D257A] Mitochondrial Mutator Mice.J Neurosci2022
35363524Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease.Sci Adv2022
35412917A high-affinity cocaine binding site associated with the brain acid soluble protein 1.Proc Natl Acad Sci U S A2022
36125899Pharmacologic inhibition of MIF nuclease: A new treatment paradigm to treat cell death.Clin Transl Med2022
35545089PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease.Cell2022
36378485Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson's Disease.CNS Drugs2022
35977929AAAâ¿¿+â¿¿ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1.Nat Commun2022
34247782CYFIP1 Dosages Exhibit Divergent Behavioral Impact via Diametric Regulation of NMDA Receptor Complex Translation in Mouse Models of Psychiatric Disorders.Biol Psychiatry2022
34323016ADP-ribosyltransferases, an update on function and nomenclature.FEBS J2022
34744054Waiting for PARIS-A Biological Target in Search of a Drug.J Parkinsons Dis2022
35172141Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological α-synuclein.Cell Rep2022
35654037Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.Neuron2022
35545089PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease.Cell2022
35394877STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.Proc Natl Acad Sci U S A2022
35363524Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease.Sci Adv2022
35412917A high-affinity cocaine binding site associated with the brain acid soluble protein 1.Proc Natl Acad Sci U S A2022
36280265The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA[D257A/D257A] Mitochondrial Mutator Mice.J Neurosci2022
36044549Amelioration of pathologic α-synuclein-induced Parkinson's disease by irisin.Proc Natl Acad Sci U S A2022
36103513Poly(ADP-ribose) promotes toxicity of <i>C9ORF72</i> arginine-rich dipeptide repeat proteins.Sci Transl Med2022
36125899Pharmacologic inhibition of MIF nuclease: A new treatment paradigm to treat cell death.Clin Transl Med2022
36378485Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson's Disease.CNS Drugs2022
35977929AAAâ¿¿+â¿¿ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1.Nat Commun2022
35172141Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological α-synuclein.Cell Rep2022
  • 1 - 50 of 778

Recommended Authors

Jeha Jeon
Department of Psychiatry and McLean Hospital, Harvard Medical School
Career Start Year 2014
Number of shared co-authors 1
Mathieu Bourdenx
University College London, UK Dementia Research Institute
Career Start Year 2013
Number of shared co-authors 8
Nima Dolatabadi
The Scripps Research Institute
Career Start Year 2010
Number of shared co-authors 3
Dorit Trudler
Tel Aviv University
Career Start Year 2010
Number of shared co-authors 3
Kelly E Glajch
Neurodegenerative Diseases Research Unit
Career Start Year 2006
Number of shared co-authors 0
Merina Varghese
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 2
Chong Li
University of Miami Miller School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Jun Peng
College of Animal Science and Technology, Huazhong Agricultural University
Career Start Year 2002
Number of shared co-authors 0
Eftekhar Eftekharpour
University of Manitoba
Career Start Year 2000
Number of shared co-authors 0
Li Gan
Helen and Robert Appel Alzheimer's Disease Research Institute
Career Start Year 1999
Number of shared co-authors 9
P Hemachandra Reddy
Texas Tech University Health Sciences Center
Career Start Year 1997
Number of shared co-authors 1
Mehrdad Shamloo
Stanford University School of Medicine
Career Start Year 1994
Number of shared co-authors 4
Ruth Luthi-Carter
University of Leicester
Career Start Year 1992
Number of shared co-authors 2
Kwang-Soo Kim
McLean Hospital and Program in Neuroscience, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 2
Eric J Huang
University of California san francisco
Career Start Year 1990
Number of shared co-authors 11
Donald C Lo
National Center for Advancing Translational Sciences
Career Start Year 1990
Number of shared co-authors 5
Steven W Barger
University of Arkansas for Medical Sciences
Career Start Year 1989
Number of shared co-authors 0
Maria Manczak
Garrison Institute on Aging, Texas Tech University Health Sciences Center
Career Start Year 1989
Number of shared co-authors 1
Gwenn A Garden
University of Washington School of Medicine
Career Start Year 1988
Number of shared co-authors 11
William T Dauer
Peter O'Donnell Jr. Brain Institute
Career Start Year 1988
Number of shared co-authors 12
Henry W Querfurth
Tufts Medical Center and Neuroscience, Tufts University
Career Start Year 1987
Number of shared co-authors 3
Eliezer Masliah
National Institute On Aging
Career Start Year 1986
Number of shared co-authors 30
Neil W Kowall
Boston University Chobanian & Avedisian School of Medicine
Career Start Year 1985
Number of shared co-authors 22
Alessandra Valerio
University of Brescia
Career Start Year 1985
Number of shared co-authors 1
Pamela J Shaw
Sheffield Institute for Translational Neuroscience, University of Sheffield
Career Start Year 1983
Number of shared co-authors 14
Raymond S Turner
Georgetown University
Career Start Year 1981
Number of shared co-authors 7
Michael P Vitek
Duke University Medical Center
Career Start Year 1981
Number of shared co-authors 3
Steven M Hersch
Inc. University Avenue
Career Start Year 1980
Number of shared co-authors 4
David A Greenberg
Abigail Wexner Research Institute, Nationwide Children's Hospital
Career Start Year 1976
Number of shared co-authors 2
William C Mobley
University of California San Diego
Career Start Year 1973
Number of shared co-authors 4

Collaborators

Ted M Dawson
Johns Hopkins University School of Medicine
Co-authored papers 366
Shaida A Andrabi
Co-authored papers 32
Solomon H Snyder
Co-authored papers 26
Juan C Troncoso
Co-authored papers 24
Jungwoo Wren Kim
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers 10
Saskia Biskup
Center for Genomics and Transcriptomics (CeGaT)
Co-authored papers 9
Ian Martin
Jungers Center for Neurosciences, Oregon Health and Science University
Co-authored papers 8
Richard J Traystman
University of Colorado
Co-authored papers 5
Akhilesh Pandey
Co-authored papers 5
Stuart A Lipton
The Scripps Research Institute, University of California
Co-authored papers 5
Carlos L??pez-Ot??n
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers 4
Seulki Lee
The Johns Hopkins University School of Medicine
Co-authored papers 4
Harry Ischiropoulos
Co-authored papers 4
Xin Guo
Co-authored papers 4
Brent R Stockwell
Columbia University
Co-authored papers 4
Rosario Rizzuto
Co-authored papers 4
Mingyao Ying
Co-authored papers 4
Simone Fulda
Co-authored papers 4
Jan Paul Medema
Oncode Institute
Co-authored papers 4
David Sulzer
New York State Psychiatric Institute, Research Foundation for Mental Hygiene
Co-authored papers 3
Changqing Yuan
Co-authored papers 3
Dennis W Dickson
Mayo Clinic Jacksonville
Co-authored papers 3
Jiang Qian
Co-authored papers 3
Evripidis Gavathiotis
Albert Einstein College of Medicine
Co-authored papers 3
Jerry E Chipuk
Co-authored papers 3
Justin C McArthur
Johns Hopkins School of Medicine
Co-authored papers 3
Brian D Dynlacht
New York University Cancer Institute, New York University School of Medicine
Co-authored papers 3
Nicola Di Daniele
University of Rome Tor Vergata
Co-authored papers 3
Peter A Calabresi
Johns Hopkins University School of Medicine
Co-authored papers 3
Leonard Petrucelli
Co-authored papers 3
Release 1.2